Corona Virus Smaller 0

Related Resources

SARS CoV 2 JN.1 Variant

U.S. DOWNLOAD THE PDF BELOW or CLICK HERE.

Canada
The products listed below have received market authorization for a “broad spectrum virucide” claim (i.e., have proven efficacy against a hard-to-kill enveloped virus) and are expected to inactivate enveloped viruses such as the SARS-CoV-2.  SARS-CoV-2 is susceptible to disinfectants that have shown efficacy against Poliovirus type 1, Human Adenovirus type 5, Bovine Parvovirus or Canine Parvovirus. Therefore these products would be expected to inactivate SARS-CoV-2.
Canada Table 2
SARS-CoV-2_FINAL_03_14_US w_List N-merged.pdf
SARS-CoV-2_FINAL_02_20 Canadav1.pdf
SARS CoV 2 JN.1 Variant